IGF-1 peptide is a prescription hormone that drives growth and cell repair. Learn how it works, who it's for, legal status in the U.S., and safety risks.
IGF-1 peptide, or insulin-like growth factor 1, is a hormone your body makes that drives growth, cell repair, and metabolism. A prescription version called mecasermin is FDA-approved for one narrow use: children with severe primary IGF-1 deficiency. IGF-1 is not approved in the United States for anti-aging, weight loss, or athletic performance.
What IGF-1 Peptide Does in the Body
IGF-1 is a 70-amino-acid peptide that travels through the bloodstream, mostly attached to carrier proteins. It tells cells to grow, divide, and survive, and it helps move glucose out of the blood and into muscle and fat tissue.
Growth hormone gets most of the attention, but many of its effects are carried out by IGF-1. The pituitary releases growth hormone; the liver responds by producing IGF-1; IGF-1 then acts on bone, cartilage, muscle, and nerve tissue.
- Growth: drives bone lengthening and tissue development in children.
- Repair: supports cell survival and regeneration after injury.
- Metabolism: helps shuttle glucose into cells and influences insulin sensitivity.
- Nerves: studied for roles in nerve protection and repair.
Medical Uses and Prescription Forms
The only FDA-approved IGF-1 medicine is mecasermin, sold under the brand name Increlex. It is given as a daily injection to children with severe primary IGF-1 deficiency or growth hormone resistance, and dosing is managed by a pediatric endocrinologist who monitors blood sugar, growth rate, and side effects.
Research compounds sold online are a different story. IGF-1 LR3 and IGF-1 DES are lab-made analogs with longer or shorter activity windows, and neither has been approved for human use. They appear often in peptide drug development, but they are not medicines.
| Form | What it is | Regulatory status | Typical setting |
|---|---|---|---|
| Mecasermin (Increlex) | Recombinant human IGF-1 | FDA-approved for severe primary IGF-1 deficiency in children | Prescribed pediatric growth therapy |
| IGF-1 LR3 | Long-acting analog | Not approved for human use | Laboratory and animal research |
| IGF-1 DES | Shortened analog | Not approved for human use | Laboratory and animal research |
IGF-1 Peptide vs. HGH
People often mix up IGF-1 and human growth hormone (HGH). Growth hormone is the signal; IGF-1 is one of the main results. Injecting HGH raises IGF-1 levels indirectly, while injecting IGF-1 bypasses the pituitary entirely.
| Feature | IGF-1 | HGH |
|---|---|---|
| Where it comes from | Liver and other tissues, in response to growth hormone | Pituitary gland |
| FDA-approved use | Severe primary IGF-1 deficiency (mecasermin) | Growth hormone deficiency, short stature, some adult deficiencies |
| Blood sugar effect | Can cause hypoglycemia | Can worsen insulin resistance |
| Common side effects | Low blood sugar, headache, tonsil or adenoid swelling in children | Joint pain, swelling, carpal tunnel symptoms |
Both are prescription-only in the United States, and both are widely counterfeited online.
Legal Status and What's Sold Online
IGF-1 is a prescription drug in the U.S. and cannot legally be sold as a dietary supplement. Mecasermin requires a prescription from a licensed provider, and importing IGF-1 for personal use is not permitted.
Most "IGF-1" sold on research chemical sites carries a "not for human consumption" label, which is a common way of selling an unapproved injectable. The peptide drug market has grown quickly, and the FDA has repeatedly warned about mislabeled, contaminated, and improperly dosed vials. If IGF-1 is marketed alongside natural peptide supplements as a wellness product, treat that as a warning sign, because real IGF-1 is a hormone rather than a supplement.
Safety, Side Effects, and Risks
The best-documented risk of IGF-1 therapy is hypoglycemia, because IGF-1 lowers blood sugar in a way that resembles insulin. Children on mecasermin need blood sugar checks and meals timed around injections.
Other reported side effects include:
- Headache and dizziness
- Swelling of the tonsils or adenoids, sometimes serious enough to require surgery
- Injection site reactions
- Rarely, increased pressure inside the skull
- Unknown risks from unregulated use, including long-term effects that have never been studied in healthy adults
Because IGF-1 promotes cell division, researchers continue to study whether persistently high levels affect cancer risk. That question is not settled, and it is one reason physicians are cautious about using IGF-1 outside its approved indication.
Who IGF-1 Peptide Therapy Is For
Mecasermin is intended for a small group: children with confirmed severe primary IGF-1 deficiency or growth hormone resistance. Adults with normal IGF-1 levels are not candidates, and there is no approved role for IGF-1 in healthy aging.
If the goal is body composition, other options have far more evidence behind them. Prescription treatments such as a glucagon-like peptide-1 receptor agonist, combined with diet and resistance training, are studied far more thoroughly than IGF-1 is. People searching for a peptide for weight loss are almost always pointed toward GLP-1 medications instead.
Anyone with concerns about growth, fatigue, or hormone levels can ask a physician to measure IGF-1 and growth hormone and explain what the results mean. Self-dosing with unapproved peptides skips that step entirely.
Key Takeaways
- IGF-1 peptide is a natural hormone that carries out many of growth hormone's effects.
- Mecasermin (Increlex) is the only FDA-approved IGF-1 medicine, and it is limited to children with severe primary IGF-1 deficiency.
- IGF-1 LR3 and IGF-1 DES are unapproved research compounds, not prescription drugs.
- Hypoglycemia is the most common serious side effect of IGF-1 therapy.
- No U.S. regulator has approved IGF-1 for anti-aging, weight loss, or athletic performance.
Frequently Asked Questions
Is IGF-1 peptide legal in the US?
IGF-1 is a prescription drug in the United States, and mecasermin (Increlex) is the only FDA-approved form. It requires a prescription from a licensed provider, and importing it for personal use is not permitted. Vials sold online as research chemicals are unapproved and are typically labeled "not for human consumption."
What does IGF-1 peptide do for muscle growth?
IGF-1 does promote muscle and tissue growth, which is why it is used illicitly in bodybuilding circles. There is no FDA approval for muscle growth or performance enhancement, and injections can cause hypoglycemia and other side effects. Most online claims about dramatic gains are anecdotal rather than supported by controlled studies.
How is IGF-1 different from HGH?
Growth hormone is released by the pituitary and signals the liver to produce IGF-1, so IGF-1 is the hormone that directly drives much of the growth response. Injecting HGH raises IGF-1 levels indirectly, while injecting IGF-1 bypasses the pituitary. Both are prescription-only in the U.S. and carry different side effect profiles.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.